Muzaffar et al., 1972 - Google Patents
Studies on fibrin formation and effects of dextranMuzaffar et al., 1972
- Document ID
- 13418144064603019672
- Author
- Muzaffar T
- Youngson G
- Bryce W
- Dhall D
- Publication year
- Publication venue
- Thrombosis and Haemostasis
External Links
Snippet
In this study highly reproducible turbidimetric techniques are used to investigate clotting of human platelet-poor plasma and purified human fibrinogen solutions by thrombin. Three phases are clearly distinguishable turbidimetrically during clotting. All the three phases are …
- 229920002307 Dextran 0 title abstract description 130
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
- G01N33/49—Blood
- G01N33/4905—Determining clotting time of blood
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Latallo et al. | Inhibition of fibrin polymerization by fibrinogen proteolysis products | |
Muzaffar et al. | Studies on fibrin formation and effects of dextran | |
Alkjaersig et al. | Pathogenesis of the coagulation defect developing during pathological plasma proteolytic (“fibrinolytic”) states. II. The significance, mechanism and consequences of defective fibrin polymerization | |
Bale et al. | Effects of thrombospondin on fibrin polymerization and structure. | |
Godal et al. | Gelation of soluble fibrin in plasma by ethanol | |
Edsall et al. | Chemical, clinical, and immunological studies on the products of human plasma fractionation. XV. The proteins concerned in the blood coagulation mechanism | |
US4011045A (en) | Turbidity reduction in triglyceride standards | |
Biggs et al. | The action of thromboplastic substances | |
US4416812A (en) | Method of preparing tissue thromboplastin | |
US3179567A (en) | Reagent and method for determining the coagulability of blood | |
Wilner et al. | Aggregation of platelets by collagen: polar active sites of insoluble human collagen | |
Niléhn et al. | Plasma Prothrombin during Treatment with Dicumarol: I. Immunochemical Determination of its Concentration in Plasma | |
JP3180824B2 (en) | Blood coagulation reagent | |
Wilf et al. | Acceleration of fibrin gel formation by unrelated proteins | |
Nanninga et al. | Preparation and properties of anticoagulant split product of fibrinogen and its determination in plasma | |
Blumberg et al. | Further evidence on the protein complexes of some hyaluronic acids | |
EP0003474A1 (en) | Method for the determination of prothrombin, reagent for this determination and process for preparing a factor Xa preparation | |
Smith et al. | Possible mechanisms for the increase in alkaline phosphatase activity of lyophilized control material | |
Silberman et al. | Effects of ancrod (Arvin) in mice: studies of plasma fibrinogen and fibrinolytic activity | |
Teger-Nilsson et al. | Fibrinogen to fibrin transformation in umbilical cord blood and purified neonatal fibrinogen | |
Sultan et al. | Immunologie Studies in von Willebrand’s Disease | |
US3993585A (en) | Elevated human lipids control | |
Ito et al. | Isozymes of bovine milk catalase | |
Kirchmaier et al. | A hemostasis activating factor (HAF) in subcutaneous tissue extracts: Effects on morphologic platelet changes, platelet retention and platelet aggregation | |
JP3180825B2 (en) | Blood coagulation measurement method |